A detailed history of Bremer Bank National Association transactions in Novo Nordisk A S stock. As of the latest transaction made, Bremer Bank National Association holds 48,555 shares of NVO stock, worth $4.13 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
48,555
Previous 50,812 4.44%
Holding current value
$4.13 Million
Previous $7.25 Million 20.28%
% of portfolio
1.1%
Previous 1.43%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$119.07 - $145.42 $268,740 - $328,212
-2,257 Reduced 4.44%
48,555 $5.78 Million
Q2 2024

Jul 16, 2024

SELL
$122.71 - $146.91 $134,735 - $161,307
-1,098 Reduced 2.12%
50,812 $7.25 Million
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $5.3 Million - $7.06 Million
51,910 New
51,910 $6.67 Million
Q2 2019

Aug 13, 2019

SELL
$46.79 - $52.47 $39,303 - $44,074
-840 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$46.36 - $52.63 $38,942 - $44,209
840 New
840 $41,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bremer Bank National Association Portfolio

Follow Bremer Bank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Bremer Bank National Association with notifications on news.